Contract 36F79721D0169
Regeneron Pharmaceuticals Inc · Department Of Veterans Affairs · June 27, 2024
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on June 27, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 12 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 26, 2026. If all options are exercised, the contract could reach $2.26 billion.
Contract details
- PIID
- 36F79721D0169
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 27, 2024
- Latest action
- March 26, 2026
Description
FSS
Modification timeline
-
March 26, 2026Mod P00054 · Supplemental Agreement For Work Within Scope$0
-
March 3, 2026Mod P00053 · Add Subcontracting Plan$0
-
February 12, 2026Mod P00052 · Supplemental Agreement For Work Within Scope$0
-
January 7, 2026Mod P00051 · Supplemental Agreement For Work Within Scope$0
-
December 16, 2025Mod P00050 · Supplemental Agreement For Work Within Scope$0
-
November 13, 2025Mod P00049 · Supplemental Agreement For Work Within Scope$0
-
October 22, 2025Mod P00048 · Supplemental Agreement For Work Within Scope$0
-
October 16, 2025Mod P00047 · Supplemental Agreement For Work Within Scope$0
-
July 28, 2025Mod P00046 · Supplemental Agreement For Work Within Scope$0
-
July 25, 2025Mod P00045 · Supplemental Agreement For Work Within Scope$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0169?
Contract 36F79721D0169 is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Veterans Affairs on June 27, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 12 times since the base award.
Who won contract 36F79721D0169?
Regeneron Pharmaceuticals Inc won contract 36F79721D0169 from Department Of Veterans Affairs.
How much is contract 36F79721D0169 worth?
Contract 36F79721D0169 has obligated $0 to date but carries a potential ceiling of $2.26 billion if fully funded and all options are exercised.